Ratings by Chardan (Matt Barcus)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/28/2023 | Applied Molecular Transport | AMTI | Downgrade | Neutral (Buy) |
0.35 (0.26) |
-25.71% | Details | |
| 12/2/2022 | Applied Molecular Transport | AMTI | Maintain | Buy (N/A) |
|
Details | ||
| 11/30/2022 | Oncorus Inc. | ONCR | Downgrade | Neutral (Buy) |
0.61 (0.12) |
-80.33% | Details | |
| 6/15/2022 | Oncorus Inc. | ONCR | New Coverage | Buy (N/A) |
1.62 (0.12) |
-92.59% | Details |
